Products
Gestrinon is no longer registered as a finished drug in many countries. Nemestran capsules were withdrawn from the market in May 2010.
Structure and properties
Gestrinone (C21H24O2, Mr = 308.4 g/mol)
Effects
Gestrinone (ATC G03XA02) is centrally antigonadotropic. It has direct antiestrogenic and antiprogestational effects on ectopic endometrium.
Indications
Endometriosis with or without infertility.
